Esophageal cancer - microbial sequence discovery
Ended Purchase Order Awarded Last action
- Contract number
- 75N91018P00493
- Awardee
-
Resphera Biosciences LLC UEI KN8XS8DJHMF1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,000
Award facts
- Contract value 100% obligated
- $24,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21231, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Resphera Biosciences LLC for $24,000 on July 2, 2018, to support esophageal cancer microbial sequence discovery research. Work is performed in Baltimore, Maryland. The order carries a firm fixed price and has an ultimate completion date of July 2, 2019.
Quick answers
Who was awarded contract 75N91018P00493?
75N91018P00493 was awarded to Resphera Biosciences LLC by National Cancer Institute (National Institutes of Health) on July 2, 2018.
How much is contract 75N91018P00493 worth?
The government has obligated $24,000 on 75N91018P00493.
Was contract 75N91018P00493 competed?
The extent of competition for 75N91018P00493 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award